Print

Idera Pharmaceuticals, Inc. (IDRA) Announces Presentation at American Academy of Dermatology Annual Meeting  
2/26/2013 6:48:55 AM

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company developing Toll-like receptor targeted drug candidates for the treatment of autoimmune diseases, today announced a presentation of preclinical data will be made by its collaborator, Dr. James G. Krueger of The Rockefeller University, at the Late-Breaking Research Symposium during the American Academy of Dermatology Annual Meeting being held March 1st through 5th, 2013, in Miami Beach, Florida.
//-->